Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT05816655

Recruiting

Comparison of Clinical Efficacy Between Letrozole + Ribociclib and Fulvestrant + Letrozole + Ribociclib in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer

Metastatic Breast Cancer
NCT05804578

Recruiting

Using a Blood Test to Monitor Metastatic Breast Cancer Treatment (BEACON)

Metastatic Breast Cancer
NCT05797454

Recruiting

Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable Breast Cancer

Breast Cancer | Breast-conserving Surgery
NCT05775575

Recruiting

A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer

Advanced Breast Cancer
NCT05759572

Recruiting

Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer

Breast Cancer Metastatic
NCT05759546

Recruiting

PARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer

Breast Cancer Metastatic
NCT05753865

Not yet recruiting

A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound)

Advanced Breast Cancer
NCT05680194

Recruiting

Prospective Research for Elderly (≥65 Years Old) Early Breast Cancer Patients (EEBC)

Breast Cancer Female
NCT05577923

Not yet recruiting

Exploring Whether Disease-free Intervals Can Guide Endocrine Combined Targeted Therapy for ER+/HER2+ Advanced Breast Cancer (T-sunflower)

Metastatic Breast Cancer
NCT05561842

Recruiting

Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)

Breast Cancer | Breast Cancer Female
NCT05507398

Not yet recruiting

The Anti-tumor Effect of Metformin And Atorvastatin in Breast Cancer

Breast Cancer Female
NCT05505357

Recruiting

Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NST (OPTIMIST) (OPTIMIST)

Breast Cancer Invasive
NCT05469750

Not yet recruiting

Dalpiciclib Plus Letrozole and Capecitabine

Advanced Breast Cancer
NCT05431504

Not yet recruiting

The Efficacy and Safety of Dalpiciclib Plus Endocrine Therapy in HR-positive / HER2-negative Advanced Breast Cancer Patients With Visceral Crisis

Advanced Breast Cancer
NCT05412225

Recruiting

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

Breast Cancer | Invasive Breast Cancer
NCT05386641

Not yet recruiting

Risk Factors for Shoulder Joint Motion Restriction

Breast Cancer Survivors
NCT05259410

Recruiting

Time Restricted Eating During Chemotherapy for Breast Cancer

Breast Cancer Female
NCT05131841

Recruiting

Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC

Metastatic Breast Cancer
NCT05047848

Recruiting

Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast Cancer

Advanced Breast Cancer
NCT04963595

Not yet recruiting

Pyrotinib and Vinorelbine Tartrate Capsules With or Without Inetetamab for First Line Treatment in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer

Metastatic Breast Cancer
NCT04856371

Not yet recruiting

Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast Cancer

Advanced Breast Cancer
NCT04824014

Recruiting

4FMFES-PET Imaging of ER+ Advanced Breast Cancers

ER+ Breast Cancer
NCT04646564

Recruiting

Radiotherapy for Extracranial Oligometastatic Breast Cancer

Breast Cancer Metastatic
NCT04641377

Recruiting

Adaptations to Breast Cancer and Exercise Using Telehealth (ABRACE: Telehealth)

Breast Cancer Female
NCT04586686

Recruiting

Combining Interventions of Fertility Preservation to Mitigate Fertility Loss After Breast Cancer (Coimbra)

Breast Cancer Female
NCT04579484

Recruiting

Determinants of Acquired Endocrine Resistance in Metastatic Breast Cancer: A Pilot Study (ENDO-RESIST)

Metastatic Breast Cancer
NCT04504747

Recruiting

Real Time Molecular Analysis of Breast Cancer Receiving Neo-adjuvant Chemotherapy (NEO-R)

Breast Cancer Female
NCT04407988

Recruiting

Pyrotinib in Combination With Letrozole in Patients With HER2-Positive, ER-Positive Metastatic Breast Cancer

Metastatic Breast Cancer
NCT04389073

Recruiting

Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine

Metastatic Breast Cancer
NCT04343079

Recruiting

Intra-operative PET-CT: a Novel Approach to Determine Excision Margins in Lumpectomy Breast Cancer.

Breast Neoplasms | Breast Cancer Female
NCT04115306

Recruiting

Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer (Dauntless-1)

Metastatic Breast Cancer
NCT03969524

Recruiting

Functional MRI in Predicting Response to Chemotherapy (MRI)

Breast Cancer Patients
NCT03959397

Not yet recruiting

Paclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast Cancer

Breast Cancer Stage
NCT03788213

Recruiting

One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer (HYPORTAdjuvant)

Breast Cancer Female
NCT03520894

Recruiting

Radiotherapy in Preoperative Setting With CyberKnife for Breast Cancer (ROCK)

Early Breast Cancer
NCT03492918

Not yet recruiting

Pembrolizumab in Combination With Paclitaxel in the Hormone Receptor-positive Metastatic Breast Cancer With High Tumor Mutational Burden Selected by Whole Exome Sequencing: Korean Cancer Study Group Trial (KCSG BR20-16)

Metastatic Breast Cancer
NCT03381092

Recruiting

Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy

Invasive Breast Cancer
NCT03351062

Recruiting

Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer

Breast Cancer Female
NCT03275311

Recruiting

Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008 (ESME-MBC)

Metastatic Breast Cancer
NCT03270007

Recruiting

Research of Intensive Treatment in Hormone Receptor<10% and Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer Patients With Positive Lymph Node Residual Disease After Neoadjuvant Chemotherapy

Primary Breast Cancer
NCT03071926

Recruiting

Metronomic PLD in Patients With Primary Endocrine Resistant ABC

Advanced Breast Cancer
NCT02102165

Recruiting

AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer. (AURORA)

Metastatic Breast Cancer
NCT07080515

Completed

Developing Screening Clinical Breast Examination Implementation Strategies in Nigeria

Breast Cancer Detection
NCT03627988

Completed

Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy. (MARTA)

Breast Cancer Invasive
NCT05085002

Terminated

A Study of Lerociclib in Participants With Advanced Breast Cancer

Advanced Breast Cancer
NCT04055493

Active, not recruiting

Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC (ADAPTcycle)

Breast Cancer Female
NCT03701334

Active, not recruiting

A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer (NATALEE)

Early Breast Cancer
NCT04653740

Active, not recruiting

Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer (OMERIC)

Advanced Breast Cancer
NCT04293393

Active, not recruiting

Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients (CARABELA)

Early Breast Cancer
NCT03272334

Active, not recruiting

Her2-BATS and Pembrolizumab in Metastatic Breast Cancer (Breast-47)

Metastatic Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations